Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Total Current Liabilities (2022 - 2025)

Historic Total Current Liabilities for 60 Degrees Pharmaceuticals (SXTP) over the last 4 years, with Q3 2025 value amounting to $2.2 million.

  • 60 Degrees Pharmaceuticals' Total Current Liabilities rose 6772.07% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 6772.07%. This contributed to the annual value of $1.7 million for FY2024, which is 4155.3% down from last year.
  • As of Q3 2025, 60 Degrees Pharmaceuticals' Total Current Liabilities stood at $2.2 million, which was up 6772.07% from $1.7 million recorded in Q2 2025.
  • 60 Degrees Pharmaceuticals' Total Current Liabilities' 5-year high stood at $28.9 million during Q2 2023, with a 5-year trough of $1.1 million in Q1 2024.
  • For the 4-year period, 60 Degrees Pharmaceuticals' Total Current Liabilities averaged around $6.3 million, with its median value being $1.8 million (2025).
  • Its Total Current Liabilities has fluctuated over the past 5 years, first tumbled by 9577.59% in 2024, then skyrocketed by 6772.07% in 2025.
  • 60 Degrees Pharmaceuticals' Total Current Liabilities (Quarter) stood at $23.9 million in 2022, then tumbled by 88.15% to $2.8 million in 2023, then crashed by 41.55% to $1.7 million in 2024, then skyrocketed by 32.6% to $2.2 million in 2025.
  • Its Total Current Liabilities stands at $2.2 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.8 million for Q1 2025.